An investigation for investors in NASDAQ:LDRH shares was announced concerning whether the takeover of medical device company LDR Holding Corp by Zimmer Biomet Holdings, Inc for $37.00 per share is unfair to NASDAQ:LDRH stockholders.
Investors who purchased shares of LDR Holding Corp (NASDAQ:LDRH) and currently hold any of those NASDAQ:LDRH shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain officers and directors of LDR Holding Corp breached their fiduciary duties owed to NASDAQ:LDRH investors in connection with the proposed acquisition.
On June 07, 2016, Zimmer Biomet Holdings, Inc. and Austin, TX based LDR Holding Corporation announced that both Boards of Directors have approved an agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR Holding Corp (NASDAQ:LDRH) for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion.
However, given that at least one analyst has set the high target price for NASDAQ::DRH shares at $40.00 per share and given that NASDAQ:LDRH shares traded as recently as July 2015 as high as $45.46 per share, the investigation concerns whether the offer is unfair to NASDAQ:LDRH stockholders. More specifically, the investigation concerns whether the LDR Holding Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
Shares of LDR Holding Corp (NASDAQ:LDRH) closed on June 17, 2016 at $37.371 per share.
Those who are current investors in NASDAQ:LDRH shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego